Tradestie Institutional Equity Comparison Engine

USPH vs PSAI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

USPH Overall Edge

USPH Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to US Physical Therapy Inc (USPH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, USPH trades at 29.6x Forward P/E with 10.2% operating margin (+13.1% YoY revenue) versus PSAI at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, USPH sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against PSAI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner USPH
USPH 29.6x vs PSAI N/M Fwd P/E
Growth & Margin Winner USPH
Op Margin 10.2% vs N/A ยท YoY +13.1% vs N/A
Momentum & Technical Winner USPH
1Y +39.8% vs +14.3% ยท 52W Pos 95% vs 91%
Options & Structure Winner USPH
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
USPH NYSE
US Physical Therapy Inc
Services-Health Services
$99.55
-0.05% 1D
Market Cap $1.5B
1M Return +16.15%
1Y Return +39.78%
Forward P/E 29.6x
Unified AI Score
31.8 / 100 SELL
Tech 50.0 Fund 25.0 Flow 50.0 Mom 30.0
PSAI US Equity
PSAI
Institutional Equity
$29.30
-0.86% 1D
Market Cap N/A
1M Return +1.91%
1Y Return +14.29%
Forward P/E N/M
Unified AI Score
54.8 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 50.0 Mom 41.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: USPH +39.78% PSAI +14.29% Spread: +54.44 pp (USPH Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
USPH TTM Op. Margin: 10.2% PSAI TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on USPH vs PSAI. Trailing 12-month operating profitability (USPH 10.2% vs PSAI N/A) and valuation multiples (USPH 29.6x vs PSAI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: USPH (8) vs PSAI (2)
Institutional Metric USPH PSAI Criterion Row Winner
Market Capitalization Scale $1.5B N/A Larger Scale USPH
Trailing P/E Ratio Valuation 32.9x N/M Lower Multiple USPH
Forward P/E Ratio Valuation 29.6x N/M Lower Multiple USPH
Revenue Growth (YoY) Growth +13.1% N/A Higher Growth USPH
Operating Margin (TTM) Profitability 10.2% N/A Higher Margin USPH
Net Profit Margin Profitability 3.6% N/A Higher Margin USPH
Return on Equity (ROE) Capital Efficiency 6.3% N/A Higher ROE USPH
52-Week Range Position Momentum 95% ($58โ€“$102) 91% ($25โ€“$30) Stronger Trend USPH
Beta / 30D Volatility Risk Regime 0.14ฮฒ ยท 42% Vol 0.80ฮฒ ยท 13% Vol Lower Realized Risk PSAI
Unified Institutional Score Composite Signal 31.8 / 100 (SELL) 54.8 / 100 (HOLD) Higher Composite PSAI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full USPH vs PSAI Buy Guide
USPH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live USPH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PSAI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PSAI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither USPH nor PSAI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.